Literature DB >> 28894986

Fertility Intentions, Pregnancy, and Use of PrEP and ART for Safer Conception Among East African HIV Serodiscordant Couples.

Renee Heffron1,2, Kerry Thomson3, Connie Celum4,3,5, Jessica Haberer6, Kenneth Ngure4,7, Nelly Mugo4,8, Elizabeth Bukusi4,9, Elly Katabira10, Josephine Odoyo9, Nulu Bulya10, Stephen Asiimwe11, Edna Tindimwebwa11, Jared M Baeten4,3,5.   

Abstract

African HIV serodiscordant couples often desire pregnancy, despite sexual HIV transmission risk during pregnancy attempts. Pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) reduce HIV risk and can be leveraged for safer conception but how well these strategies are used for safer conception is not known. We conducted an open-label demonstration project of the integrated delivery of PrEP and ART among 1013 HIV serodiscordant couples from Kenya and Uganda followed quarterly for 2 years. We evaluated fertility intentions, pregnancy incidence, the use of PrEP and ART during peri-conception, and peri-conception HIV incidence. At enrollment, 80% of couples indicated a desire for more children. Pregnancy incidence rates were 18.5 and 18.7 per 100 person years among HIV-uninfected and HIV-infected women, and higher among women who recently reported fertility intention (adjusted odds ratio 3.43, 95% CI 2.38-4.93) in multivariable GEE models. During the 6 months preceding pregnancy, 82.9% of couples used PrEP or ART and there were no HIV seroconversions. In this cohort with high pregnancy rates, integrated PrEP and ART was readily used by HIV serodiscordant couples, including during peri-conception periods. Widespread scale-up of safer conception counseling and services is warranted to respond to strong desires for pregnancy among HIV-affected men and women.

Entities:  

Keywords:  ART; Africa; Discordant couples; PrEP; Pregnancy; Safer conception

Mesh:

Substances:

Year:  2018        PMID: 28894986      PMCID: PMC5845763          DOI: 10.1007/s10461-017-1902-7

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  13 in total

1.  Safe conception for human immunodeficiency virus-discordant couples: the preexposure prophylaxis for conception alternative.

Authors:  Gabriella De Carli; Antonio Palummieri; Giuseppina Liuzzi; Vincenzo Puro
Journal:  Am J Obstet Gynecol       Date:  2013-08-14       Impact factor: 8.661

2.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

3.  My intention was a child but I was very afraid: fertility intentions and HIV risk perceptions among HIV-serodiscordant couples experiencing pregnancy in Kenya.

Authors:  Kenneth Ngure; Jared M Baeten; Nelly Mugo; Kathryn Curran; Sophie Vusha; Renee Heffron; Connie Celum; Bettina Shell-Duncan
Journal:  AIDS Care       Date:  2014-04-29

4.  Fertility Decision-Making Among Kenyan HIV-Serodiscordant Couples Who Recently Conceived: Implications for Safer Conception Planning.

Authors:  Jillian Pintye; Kenneth Ngure; Kathryn Curran; Sophie Vusha; Nelly Mugo; Connie Celum; Jared M Baeten; Renee Heffron
Journal:  AIDS Patient Care STDS       Date:  2015-09       Impact factor: 5.078

5.  Safe conception for HIV-discordant couples: insemination with processed semen from the HIV-infected partner.

Authors:  Augusto Enrico Semprini; Maurizio Macaluso; Lital Hollander; Alessandra Vucetich; Ann Duerr; Gil Mor; Marina Ravizza; Denise J Jamieson
Journal:  Am J Obstet Gynecol       Date:  2013-02-08       Impact factor: 8.661

6.  Insemination of HIV-negative women with processed semen of HIV-positive partners.

Authors:  A E Semprini; P Levi-Setti; M Bozzo; M Ravizza; A Taglioretti; P Sulpizio; E Albani; M Oneta; G Pardi
Journal:  Lancet       Date:  1992-11-28       Impact factor: 79.321

7.  An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention.

Authors:  Erin M Kahle; James P Hughes; Jairam R Lingappa; Grace John-Stewart; Connie Celum; Edith Nakku-Joloba; Stella Njuguna; Nelly Mugo; Elizabeth Bukusi; Rachel Manongi; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

8.  Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.

Authors:  Jared M Baeten; Renee Heffron; Lara Kidoguchi; Nelly R Mugo; Elly Katabira; Elizabeth A Bukusi; Stephen Asiimwe; Jessica E Haberer; Jennifer Morton; Kenneth Ngure; Nulu Bulya; Josephine Odoyo; Edna Tindimwebwa; Craig Hendrix; Mark A Marzinke; Norma C Ware; Monique A Wyatt; Susan Morrison; Harald Haugen; Andrew Mujugira; Deborah Donnell; Connie Celum
Journal:  PLoS Med       Date:  2016-08-23       Impact factor: 11.069

9.  Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.

Authors:  Jennifer F Morton; Connie Celum; John Njoroge; Agnes Nakyanzi; Imeldah Wakhungu; Edna Tindimwebwa; Snaidah Ongachi; Eric Sedah; Emmanuel Okwero; Kenneth Ngure; Josephine Odoyo; Nulu Bulya; Jessica E Haberer; Jared M Baeten; Renee Heffron
Journal:  J Acquir Immune Defic Syndr       Date:  2017-01-01       Impact factor: 3.731

10.  A discussion of key values to inform the design and delivery of services for HIV-affected women and couples attempting pregnancy in resource-constrained settings.

Authors:  Renee Heffron; Natasha Davies; Ian Cooke; Angela Kaida; Reid Mergler; Sheryl van der Poel; Craig R Cohen; Okeoma Mmeje
Journal:  J Int AIDS Soc       Date:  2015-12-01       Impact factor: 5.396

View more
  17 in total

Review 1.  PrEP rollout in Africa: status and opportunity.

Authors:  Elizabeth M Irungu; Jared M Baeten
Journal:  Nat Med       Date:  2020-05-11       Impact factor: 53.440

2.  HIV Pre-Exposure Prophylaxis for Conception Among HIV Serodiscordant Couples in the United States: A Cohort Study.

Authors:  Ashley A Leech; Dea Biancarelli; Erika Aaron; Emily S Miller; Jenell S Coleman; Peter L Anderson; Hervette Nkwihoreze; Brianne Condron; Meg Sullivan
Journal:  AIDS Patient Care STDS       Date:  2020-07       Impact factor: 5.078

3.  HIV incidence, pregnancy, and implementation outcomes from the Sakh'umndeni safer conception project in South Africa: a prospective cohort study.

Authors:  Sheree R Schwartz; Jean Bassett; Lillian Mutunga; Nompumelelo Yende; Mutsa Mudavanhu; Rebecca Phofa; Ian Sanne; Annelies Van Rie
Journal:  Lancet HIV       Date:  2019-05-31       Impact factor: 12.767

4.  The Intersection of HIV, Social Vulnerability, and Reproductive Health: Analysis of Women Living with HIV in Rio de Janeiro, Brazil from 1996 to 2016.

Authors:  Christine M Zachek; Lara E Coelho; Rosa M S M Domingues; Jesse L Clark; Raquel B De Boni; Paula M Luz; Ruth K Friedman; Ângela C Vasconcelos de Andrade; Valdilea G Veloso; Jordan E Lake; Beatriz Grinsztejn
Journal:  AIDS Behav       Date:  2019-06

5.  HIV pre-exposure prophylaxis: assessment of acceptability among members of HIV serodiscordant/serostatus unknown couples.

Authors:  Edith Bracho-Sanchez; Samantha Stonbraker; Mina Halpern; Sarah Wood; Elizabeth Lowenthal
Journal:  Int J STD AIDS       Date:  2022-04-29       Impact factor: 1.456

6.  HIV-Uninfected Kenyan Adolescent and Young Women Share Perspectives on Using Pre-Exposure Prophylaxis During Pregnancy.

Authors:  Jillian Pintye; Kristin M Beima-Sofie; Pamela A Makabong'O; Anne Njoroge; Susan Brown Trinidad; Renee A Heffron; Jared M Baeten; Connie Celum; Daniel Matemo; John Kinuthia; Maureen C Kelley; Grace C John-Stewart
Journal:  AIDS Patient Care STDS       Date:  2018-07-23       Impact factor: 5.078

7.  Defining gaps in pre-exposure prophylaxis delivery for pregnant and post-partum women in high-burden settings using an implementation science framework.

Authors:  Jillian Pintye; Dvora L Joseph Davey; Anjuli D Wagner; Grace John-Stewart; Rachel Baggaley; Linda-Gail Bekker; Connie Celum; Benjamin H Chi; Thomas J Coates; Allison K Groves; Jessica E Haberer; Renee Heffron; John Kinuthia; Lynn T Matthews; James A McIntyre; Dhayendre Moodley; Lynne M Mofenson; Nelly Mugo; Andrew Mujugira; Landon Myer; Steven Shoptaw; Lynda Stranix-Chibanda; Jared M Baeten
Journal:  Lancet HIV       Date:  2020-08       Impact factor: 12.767

8.  Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa.

Authors:  Renee Heffron; Kenneth Ngure; Josephine Odoyo; Nulu Bulya; Edna Tindimwebwa; Ting Hong; Lara Kidoguchi; Deborah Donnell; Nelly R Mugo; Elizabeth A Bukusi; Elly Katabira; Stephen Asiimwe; Jennifer Morton; Susan Morrison; Harald Haugen; Andrew Mujugira; Jessica E Haberer; Norma C Ware; Monique A Wyatt; Mark A Marzinke; Lisa M Frenkel; Connie Celum; Jared M Baeten
Journal:  Gates Open Res       Date:  2018-01-30

9.  Magnitude of anemia and associated factors among children aged 6-59 months at Debre Markos referral hospital, Northwest Ethiopia: a hospital-based cross-sectional study.

Authors:  Yoseph Merkeb Alamneh; Tadesse Yirga Akalu; Abtie Abebaw Shiferaw; Aytenew Atnaf
Journal:  Ital J Pediatr       Date:  2021-08-13       Impact factor: 2.638

10.  Fertility among women living with HIV in western Ethiopia and its implications for prevention of vertical transmission: a cross-sectional study.

Authors:  Tesfaye Regassa Feyissa; Melissa L Harris; Peta M Forder; Deborah Loxton
Journal:  BMJ Open       Date:  2020-08-20       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.